The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Merck
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Merck
Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study.
 
Padmanee Sharma
Stock and Other Ownership Interests - Jounce Therapeutics; Kite, a Gilead company
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Jounce Therapeutics; Kite, a Gilead company
 
Petri Bono
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Orion; Pfizer
 
Joseph W. Kim
Consulting or Advisory Role - Dendreon
Research Funding - Immune Design
 
Pavlina Spiliopoulou
No Relationships to Disclose
 
Emiliano Calvo
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Lilly/ImClone; Nanobiotix; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen Oncology; Lilly; Merck; Millennium; Nektar; Novartis; OncoMed; Pfizer; PharmaMar; PsiOxus Therapeutics; Puma Biotechnology; Roche/Genentech; Sanofi; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Lilly; Novartis; PsiOxus Therapeutics
Other Relationship - Pierre Fabre
 
Rathi Narayana Pillai
No Relationships to Disclose
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; AstraZeneca; Bristol-Myers Squibb; Merck
 
Filippo G. De Braud
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Novartis; SERVIER
 
Michael A. Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Boehringer Ingelheim; EMD Serono; Etubics; Genentech/Roche; Ipsen; Lexicon; Merrimack; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Novartis
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Dung T Le
No Relationships to Disclose
 
Dirk Jaeger
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche
 
Emily Chan
Consulting or Advisory Role - Amgen; Bayer; Castle Biosciences; Lilly; Taiho Pharmaceutical
Research Funding - Aduro Biotech; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Dekkun Corporation; Halozyme; Karyopharm Therapeutics; Merrimack; Millennium; Taiho Pharmaceutical
 
Christopher T. Harbison
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Chen-Sheng Lin
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Marina Tschaika
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Alex Azrilevich
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jonathan Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - UpToDate
Consulting or Advisory Role - Agensys; Boehringer Ingelheim; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Johnson & Johnson; Lilly; Merck; OncoGenex; Onyx; Roche/Genentech; Sanofi
Research Funding - Agensys (Inst); Genentech (Inst); Mirati Therapeutics (Inst); Novartis (Inst); OncoGenex (Inst)
Patents, Royalties, Other Intellectual Property - ERCC2 predicting cisplatin sensitivity
Travel, Accommodations, Expenses - Genentech/Roche